Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery
Sponsor
Patrick Meybohm (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00882622
Collaborator
University Hospital Frankfurt (Other)
0
2
2
0
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate the effects of Remote Ischemic Preconditioning on cardiac function in patients undergoing cardiac surgery compared to control intervention.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Detailed Description
In detail, we will focus on new onset of atrial fibrillation, ventricular arrhythmias, myocardial injury, and cardiac function. Furthermore, we aim to investigate underlying pathways of RIPC in modifying the perioperative stress response.
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery
Study Start Date
:
Feb 1, 2009
Actual Primary Completion Date
:
Feb 1, 2009
Actual Study Completion Date
:
Feb 1, 2009
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: RIPC
|
Procedure: Remote Ischemic Preconditioning
RIPC will be induced during anesthesia by four 5-min cycles of upper limb ischemia and 5-min reperfusion using a blood-pressure cuff inflated to a pressure 15 mm Hg greater than the systolic arterial pressure measured via the arterial line.
|
Sham Comparator: CONTROL
|
Procedure: Control/sham procedure
Sham placement of the blood pressure cuff around the upper limb without inflation.
|
Outcome Measures
Primary Outcome Measures
- New onset of atrial fibrillation [Within 30 days after surgery]
Secondary Outcome Measures
- Ventricular arrhythmias, myocardial injury, cardiac function. Underlying pathways of Remote Ischemic Preconditioning in modifying the perioperative stress response. [Within 24 hours after surgery]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patient undergoing heart surgery on cardiopulmonary bypass
Exclusion Criteria:
-
Emergency cases
-
Myocardial infarction up to 7 days prior to enrollment
-
Ejection fraction less than 30%
-
Inability to give informed consent
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital | Frankfurt am Main | Germany | ||
2 | University Hospital Schleswig-Holstein | Kiel | Germany | 24105 |
Sponsors and Collaborators
- Patrick Meybohm
- University Hospital Frankfurt
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Patrick Meybohm,
PD Dr.,
University Hospital Schleswig-Holstein
ClinicalTrials.gov Identifier:
NCT00882622
Other Study ID Numbers:
- A165/08_2
First Posted:
Apr 16, 2009
Last Update Posted:
Jan 18, 2012
Last Verified:
Jan 1, 2012
Keywords provided by Patrick Meybohm,
PD Dr.,
University Hospital Schleswig-Holstein
Additional relevant MeSH terms: